Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|April 1, 2003
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120Sudhir Paul, Stephanie Planque, Yong-Xin Zhou, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concernPayton A-B Weidenbacher, Natalia Friedland, Mrinmoy Sanyal, et al.
The Journal of Biological Chemistry|July 23, 2004
Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120Sudhir Paul, Sangeeta Karle, Stephanie Planque, et al.
Emerging Infectious Diseases|September 1, 2021
Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USAKrishna Surasi, Kristin J Cummings, Carl Hanson, et al.
International Journal of Neonatal Screening|August 22, 2023
Shadow of a Pandemic: Persistence of Prenatal SARS-CoV-2 Antibodies in Newborn Blood SpotsStanley Sciortino, Steve Graham, Toki Fillman, et al.
Scientific Reports|July 3, 2025
Differential immunity induced by Omicron sublineages in naïve and vaccine breakthrough infectionsNoah Brazer, Mary Kate Morris, Venice Servellita, et al.
Water Research|July 31, 2020
Water tracking in surface water, groundwater and soils using free and alginate-chitosan encapsulated synthetic DNA tracersLiping Pang, Gayan Abeysekera, Kyrin Hanning, et al.
AIDS Research and Human Retroviruses|December 28, 2007
Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infectionStephanie Planque, Yukie Mitsuda, Hiroaki Taguchi, et al.
Plos Neglected Tropical Diseases|August 8, 2022
Epidemiologic and environmental characterization of the Re-emergence of St. Louis Encephalitis Virus in California, 2015-2020Mary E Danforth, Robert E Snyder, Tina Feiszli, et al.
Nature Chemical Biology|September 8, 2022
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitorsPayton A-B Weidenbacher, Eric Waltari, Izumi de Los Rios Kobara, et al.
Pageof 4